vs
Side-by-side financial comparison of P3 Health Partners Inc. (PIII) and UNISYS CORP (UIS). Click either name above to swap in a different company.
UNISYS CORP is the larger business by last-quarter revenue ($574.5M vs $384.8M, roughly 1.5× P3 Health Partners Inc.). UNISYS CORP runs the higher net margin — 3.3% vs -19.6%, a 22.9% gap on every dollar of revenue. On growth, UNISYS CORP posted the faster year-over-year revenue change (5.3% vs 3.8%). Over the past eight quarters, UNISYS CORP's revenue compounded faster (8.5% CAGR vs -0.5%).
P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.
Unisys Corporation is a technology company founded in 1986 and headquartered in Blue Bell, Pennsylvania. The company provides cloud, AI, digital workplace, logistics, and enterprise computing services.
PIII vs UIS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $384.8M | $574.5M |
| Net Profit | $-75.5M | $18.7M |
| Gross Margin | — | 33.9% |
| Operating Margin | -40.0% | 13.3% |
| Net Margin | -19.6% | 3.3% |
| Revenue YoY | 3.8% | 5.3% |
| Net Profit YoY | -28.8% | -37.7% |
| EPS (diluted) | $-23.08 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $384.8M | $574.5M | ||
| Q3 25 | $345.3M | $460.2M | ||
| Q2 25 | $355.8M | $483.3M | ||
| Q1 25 | $373.2M | $432.1M | ||
| Q4 24 | $370.7M | $545.4M | ||
| Q3 24 | $362.1M | $497.0M | ||
| Q2 24 | $379.2M | $478.2M | ||
| Q1 24 | $388.5M | $487.8M |
| Q4 25 | $-75.5M | $18.7M | ||
| Q3 25 | $-31.6M | $-308.9M | ||
| Q2 25 | $-20.4M | $-20.1M | ||
| Q1 25 | $-20.5M | $-29.5M | ||
| Q4 24 | $-58.6M | $30.0M | ||
| Q3 24 | $-46.5M | $-61.9M | ||
| Q2 24 | $-12.0M | $-12.0M | ||
| Q1 24 | $-18.7M | $-149.5M |
| Q4 25 | — | 33.9% | ||
| Q3 25 | — | 25.5% | ||
| Q2 25 | — | 26.9% | ||
| Q1 25 | — | 24.9% | ||
| Q4 24 | — | 32.1% | ||
| Q3 24 | — | 29.2% | ||
| Q2 24 | — | 27.2% | ||
| Q1 24 | — | 27.9% |
| Q4 25 | -40.0% | 13.3% | ||
| Q3 25 | -12.8% | -7.3% | ||
| Q2 25 | -9.6% | 6.3% | ||
| Q1 25 | -10.2% | 1.2% | ||
| Q4 24 | -37.4% | 8.9% | ||
| Q3 24 | -29.5% | 1.5% | ||
| Q2 24 | -8.3% | 4.9% | ||
| Q1 24 | -11.3% | 3.6% |
| Q4 25 | -19.6% | 3.3% | ||
| Q3 25 | -9.1% | -67.1% | ||
| Q2 25 | -5.7% | -4.2% | ||
| Q1 25 | -5.5% | -6.8% | ||
| Q4 24 | -15.8% | 5.5% | ||
| Q3 24 | -12.8% | -12.5% | ||
| Q2 24 | -3.2% | -2.5% | ||
| Q1 24 | -4.8% | -30.6% |
| Q4 25 | $-23.08 | $0.24 | ||
| Q3 25 | $-9.67 | $-4.33 | ||
| Q2 25 | $-6.23 | $-0.28 | ||
| Q1 25 | $-6.28 | $-0.42 | ||
| Q4 24 | $-23.13 | $0.45 | ||
| Q3 24 | $-15.70 | $-0.89 | ||
| Q2 24 | $-7.37 | $-0.17 | ||
| Q1 24 | $-7.86 | $-2.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $25.0M | $413.9M |
| Total DebtLower is stronger | $228.4M | $729.0M |
| Stockholders' EquityBook value | $-155.2M | $-282.6M |
| Total Assets | $656.6M | $1.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $25.0M | $413.9M | ||
| Q3 25 | $37.7M | $321.9M | ||
| Q2 25 | $38.6M | $300.8M | ||
| Q1 25 | $40.1M | $393.1M | ||
| Q4 24 | $38.8M | $376.5M | ||
| Q3 24 | $63.0M | $373.7M | ||
| Q2 24 | $73.1M | $344.9M | ||
| Q1 24 | $27.3M | $382.8M |
| Q4 25 | $228.4M | $729.0M | ||
| Q3 25 | $252.8M | $723.2M | ||
| Q2 25 | $182.0M | $692.7M | ||
| Q1 25 | $171.1M | $488.3M | ||
| Q4 24 | $108.9M | $488.2M | ||
| Q3 24 | $133.2M | $488.5M | ||
| Q2 24 | $133.1M | $489.2M | ||
| Q1 24 | $118.1M | $488.4M |
| Q4 25 | $-155.2M | $-282.6M | ||
| Q3 25 | $-18.7M | $-300.2M | ||
| Q2 25 | $44.5M | $-221.5M | ||
| Q1 25 | $63.3M | $-267.8M | ||
| Q4 24 | $75.9M | $-283.4M | ||
| Q3 24 | $120.5M | $-202.2M | ||
| Q2 24 | $166.8M | $-174.1M | ||
| Q1 24 | $146.6M | $-158.6M |
| Q4 25 | $656.6M | $1.8B | ||
| Q3 25 | $683.6M | $1.7B | ||
| Q2 25 | $731.6M | $1.8B | ||
| Q1 25 | $783.9M | $1.8B | ||
| Q4 24 | $783.4M | $1.9B | ||
| Q3 24 | $833.3M | $1.9B | ||
| Q2 24 | $892.8M | $1.9B | ||
| Q1 24 | $855.9M | $1.9B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.09× | — | ||
| Q1 25 | 2.71× | — | ||
| Q4 24 | 1.43× | — | ||
| Q3 24 | 1.11× | — | ||
| Q2 24 | 0.80× | — | ||
| Q1 24 | 0.81× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.7M | $104.9M |
| Free Cash FlowOCF − Capex | — | $97.3M |
| FCF MarginFCF / Revenue | — | 16.9% |
| Capex IntensityCapex / Revenue | — | 1.3% |
| Cash ConversionOCF / Net Profit | — | 5.61× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-170.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-25.7M | $104.9M | ||
| Q3 25 | $-15.4M | $38.0M | ||
| Q2 25 | $-16.6M | $-316.2M | ||
| Q1 25 | $-33.5M | $33.3M | ||
| Q4 24 | $-57.2M | $76.6M | ||
| Q3 24 | $-22.6M | $32.0M | ||
| Q2 24 | $-10.2M | $2.7M | ||
| Q1 24 | $-20.0M | $23.8M |
| Q4 25 | — | $97.3M | ||
| Q3 25 | — | $32.4M | ||
| Q2 25 | — | $-324.1M | ||
| Q1 25 | — | $24.4M | ||
| Q4 24 | — | $66.5M | ||
| Q3 24 | — | $25.2M | ||
| Q2 24 | — | $-6.0M | ||
| Q1 24 | — | $17.1M |
| Q4 25 | — | 16.9% | ||
| Q3 25 | — | 7.0% | ||
| Q2 25 | — | -67.1% | ||
| Q1 25 | — | 5.6% | ||
| Q4 24 | — | 12.2% | ||
| Q3 24 | — | 5.1% | ||
| Q2 24 | — | -1.3% | ||
| Q1 24 | — | 3.5% |
| Q4 25 | — | 1.3% | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | — | 1.6% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | 0.0% | 1.9% | ||
| Q3 24 | 0.0% | 1.4% | ||
| Q2 24 | 0.0% | 1.8% | ||
| Q1 24 | 0.0% | 1.4% |
| Q4 25 | — | 5.61× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.55× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
UIS
Segment breakdown not available.
